ARCHIVES

Revlimid Extends Time To Progression Compared To Placebo In Phase III Trial

This article is from The Cancer Letter archive.

Vol. 32 No. 12 | December 25, 2009

Download PDF Visit The Full Archive

Related Articles

JR Adams Elected President, Ovarian Cancer Coalition.

March 9, 2001

In Brief: Hedlund To Head Prostate Cancer Coalition; USCF Forms Human Genetics Program

July 25, 1997

NIH Backs Down Agrees Nurses May Be Hired Into Commissioned Corps

June 13, 1986

In Brief: $7 Mil. Gift allows USC To Expand Gene Therapy; North Carolina Passes Off-Label Drug Legislation

September 3, 1993

CCOP Controversy Goes On: DCT Board Objects, Says It Was Left Out; Moorhead, DeVita Clarify Positions

February 19, 1982

Boundary; Opponents Of CMS Policy Step Up The Fight.

November 9, 2007